Rapid Sequence Intubation Drug Delivery Using Intraosseous and IV Access in Pediatric Patients Observational Study
Withdrawn before enrolling
Conditions studied: Airway Control
In brief
This study will evaluate using intraosseous vascular access and intravenous vascular access to give pediatric patients the necessary medications to perform rapid sequence intubation, for patients with airway difficulties.
Key facts
- Study ID
- NCT01634867
- Run by
- Vidacare Corporation
- People needed
- 0
- Starts
- 2012-09-01
- Expected to finish
- 2014-08-01
- Last updated by the study team
- 2026-04-02
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- subjects requiring rapid sequence intubation for whom rocuronium is chosen as the paralytic agent.
- the operator chooses to place a peripheral intravenous or powered intraosseous catheter to permit rapid sequence intubation.
You may not qualify if…
- subjects in whom vascular access for rapid sequence intubation drug administration was established prior to arrival to the emergency department.
Where it is running
- Omaha Children's Hospital and Medical Center — Omaha, Nebraska, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.